The role of tumour-associated MUC1 in epithelial ovarian cancer metastasis and progression
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of tumour-associated MUC1 in epithelial ovarian cancer metastasis and progression
Authors
Keywords
MUC1, Epithelial ovarian cancer, Tumour-associated antigen, Metastasis, Targeted cancer therapy
Journal
CANCER AND METASTASIS REVIEWS
Volume 32, Issue 3-4, Pages 535-551
Publisher
Springer Nature
Online
2013-04-22
DOI
10.1007/s10555-013-9423-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Reversal of Paclitaxel Resistance in Epithelial Ovarian Carcinoma Cells by a MUC1 Aptamer-let-7i Chimera
- (2012) Nenghui Liu et al. CANCER INVESTIGATION
- Immunobiology of human mucin 1 in a preclinical ovarian tumor model
- (2012) R A Budiu et al. ONCOGENE
- Novel MUC1 Aptamer Selectively Delivers Cytotoxic Agent to Cancer Cells In Vitro
- (2012) Yan Hu et al. PLoS One
- MUC1-C oncoprotein confers androgen-independent growth of human prostate cancer cells
- (2012) Hasan Rajabi et al. PROSTATE
- Involvement of autophagy in ovarian cancer: a working hypothesis
- (2012) Claudia Peracchio et al. Journal of Ovarian Research
- Epithelial–Mesenchymal Transition in Ovarian Carcinoma
- (2012) Ben Davidson et al. Frontiers in Oncology
- Proteomic biomarkers in combination with CA 125 for detection of epithelial ovarian cancer using prediagnostic serum samples from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
- (2011) Lee E. Moore et al. CANCER
- Soluble MUC1 and serum MUC1-specific antibodies are potential prognostic biomarkers for platinum-resistant ovarian cancer
- (2011) Raluca A. Budiu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer
- (2011) Ronak Savla et al. JOURNAL OF CONTROLLED RELEASE
- Anti-MUC1 Monoclonal Antibody (C595) and Docetaxel Markedly Reduce Tumor Burden and Ascites, and Prolong Survival in an in vivo Ovarian Cancer Model
- (2011) Li Wang et al. PLoS One
- Bismuth-213 radioimmunotherapy with C595 anti–MUC1 monoclonal antibody in an ovarian cancer ascites model
- (2010) Emma Y. Song et al. CANCER BIOLOGY & THERAPY
- Monoclonal antibody targeting MUC1 and increasing sensitivity to docetaxel as a novel strategy in treating human epithelial ovarian cancer
- (2010) Li Wang et al. CANCER LETTERS
- Cancer Biomarkers Defined by Autoantibody Signatures to Aberrant O-Glycopeptide Epitopes
- (2010) H. H. Wandall et al. CANCER RESEARCH
- Epithelial Mesenchymal Transition and Cancer Stem Cell-Like Phenotypes Facilitate Chemoresistance in Recurrent Ovarian Cancer
- (2010) N. Ahmed et al. CURRENT CANCER DRUG TARGETS
- Current clinical use of biomarkers for epithelial ovarian cancer
- (2010) Richard G Moore et al. CURRENT OPINION IN ONCOLOGY
- Expression of aberrantly glycosylated Mucin-1 in ovarian cancer
- (2010) Catharina H M J Van Elssen et al. HISTOPATHOLOGY
- MUC1 regulates nuclear localization and function of the epidermal growth factor receptor
- (2010) B. G. Bitler et al. JOURNAL OF CELL SCIENCE
- Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis
- (2010) Qicheng Zhao et al. Molecular Cancer
- MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition
- (2010) L D Roy et al. ONCOGENE
- Epithelial–mesenchymal transition in ovarian cancer
- (2009) Daniele Vergara et al. CANCER LETTERS
- Direct Targeting of the Mucin 1 Oncoprotein Blocks Survival and Tumorigenicity of Human Breast Carcinoma Cells
- (2009) D. Raina et al. CANCER RESEARCH
- Circulating Galectin-3 Promotes Metastasis by Modifying MUC1 Localization on Cancer Cell Surface
- (2009) Q. Zhao et al. CANCER RESEARCH
- Molecular Assembly of an Aptamer-Drug Conjugate for Targeted Drug Delivery to Tumor Cells
- (2009) Yu-Fen Huang et al. CHEMBIOCHEM
- The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
- (2009) M. A. Cheever et al. CLINICAL CANCER RESEARCH
- Use of monoclonal antibodies in the treatment of ovarian cancer
- (2009) Seiji Mabuchi et al. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- Preclinical studies and clinical utilization of monoclonal antibodies in epithelial ovarian cancer
- (2009) Peter J. Frederick et al. GYNECOLOGIC ONCOLOGY
- Intracellular MUC1 Peptides Inhibit Cancer Progression
- (2008) B. G. Bitler et al. CLINICAL CANCER RESEARCH
- Mucin overexpression limits the effectiveness of 5-FU by reducing intracellular drug uptake and antineoplastic drug effects in pancreatic tumours
- (2008) Ashish V. Kalra et al. EUROPEAN JOURNAL OF CANCER
- Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence
- (2008) Laura J. Havrilesky et al. GYNECOLOGIC ONCOLOGY
- Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer
- (2008) Kirstine Roepstorff et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Phototoxic aptamers selectively enter and kill epithelial cancer cells
- (2008) Cátia S. M. Ferreira et al. NUCLEIC ACIDS RESEARCH
- Structure and Function of the Cell Surface (Tethered) Mucins
- (2007) Christine L. Hattrup et al. Annual Review of Physiology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search